Skip to main content

Bank of New York Mellon Corp

Bank

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1390777 NEW YORK, NY

Position in LFCR

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$217,493
-$264,210 QoQ
Shares Held
58,466
-0.7% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $1,372,047,844 across 46 Drug Manufacturers - Specialty & Generic names. LFCR ranks #42 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LFCR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $217,493 58,466
2025-12-31 $481,703 58,888
2025-09-30 $624,591 84,863
2025-06-30 $674,576 83,076
2025-03-31 $588,987 83,663
2024-12-31 $598,649 80,572
2024-09-30 $231,128 46,882
2024-06-30 $327,170 63,776
2023-12-31 $127,309 20,567
2023-09-30 $185,842 24,615
2023-06-30 $258,382 26,720
2023-03-31 $404,580 107,032
2022-12-31 $693,534 107,027
2022-09-30 $951,816 107,066
2022-06-30 $967,827 97,074
2022-03-31 $1,272,919 109,924
2021-12-31 $1,254,455 113,014
2021-09-30 $1,029,578 111,668
2021-06-30 $2,694,531 239,514
2021-03-31 $2,388,646 225,344
2020-09-30 $2,275,800 234,136
2020-06-30 $1,792,320 225,166
2020-03-31 $2,459,426 283,018